Literature DB >> 6356890

Drug prescribing in renal failure: dosing guidelines for adults.

W M Bennett, G R Aronoff, G Morrison, T A Golper, J Pulliam, M Wolfson, I Singer.   

Abstract

The data base for rational guidelines to safe, efficacious drug prescribing in adults with renal insufficiency are presented in tabular form. Current medical literature was extensively surveyed to provide as much specific information as possible. When information is lacking, however, recommendations are based on pharmacokinetic variables in normal subjects. Nephrotoxicity, important adverse effects, and special considerations in renal patients are noted. Adjustments are suggested for hemodialysis and peritoneal dialysis when appropriate.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356890     DOI: 10.1016/s0272-6386(83)80060-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  34 in total

Review 1.  Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.

Authors:  Masatoshi Tomita; Yoichi Aoki; Kenichi Tanaka
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Double-blind randomized study of the effect of infusion rates on toxicity of amphotericin B.

Authors:  M E Ellis; A A al-Hokail; H M Clink; M A Padmos; P Ernst; D G Spence; W N Tharpe; V F Hillier
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 3.  Pharmacokinetics of continuous renal replacement therapy.

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 4.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 5.  Pharmacokinetics and pharmacodynamics in critically ill patients.

Authors:  H J Mann; D W Fuhs; F B Cerra
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

Review 6.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

7.  Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?

Authors:  Youssef Bennis; Amandine Savry; Magali Rocca; Laurence Gauthier-Villano; Pascale Pisano; Bertrand Pourroy
Journal:  Int J Clin Pharm       Date:  2014-01-17

8.  Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.

Authors:  P Somani; E H Freimer; M L Gross; J T Higgins
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Pharmacokinetics of cefonicid in patients with skin and skin structure infections.

Authors:  K L Heim-Duthoy; G L Peltier; D R Guay; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

10.  Drug dosage in end-stage renal disease (ESRD) patients undergoing haemodialysis. A predictive study based on a microcomputer program.

Authors:  M V Mac-Kay; J Sanchez Burson; J Martinez-Lanao; A Dominguez-Gil
Journal:  Clin Pharmacokinet       Date:  1993-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.